Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 10 Million Yuan Net Loss in First Quarter of 2023

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 10 million yuan in the first quarter of 2023, widening 41.8% year-on-year.

Meanwhile, the company posted 22.3 million yuan in revenue, down 14.6% year-on-year.

At the end of the reporting period, it had 284.2 million yuan in total assets and 289.7 million yuan in total liabilities, with a liability-to-asset ratio of 101.9%.